1-2 of 2
Matthew O'Rourke
Close
Sort by
Journal Articles

First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to Eliminate Endogenous TCR and PD-1 (NYCE T cells) in Advanced Multiple Myeloma (MM) and Sarcoma

Edward A. Stadtmauer, MD FACP, Adam D. Cohen, MD, Kristy Weber, MD, Simon F Lacey, PhD, Vanessa E. Gonzalez, J. Joseph Melenhorst, PhD, Joseph A Fraietta, PhD, Gabriela Plesa, MD, Joanne Shea, Tina Matlawski, RN, Amanda Cervini, RN, Patricia Mangan, CRNP, Avery Gaymon, Stephanie Desjardins, Eric Lancaster, MD, January Salas-Mckee, Megan M. Suhoski, PhD, Andrew Fesnak, MD, Matthew O'Rourke, Anne Lamontagne, Don L. Siegel, MD PhD, Regina M Young, PhD, Anne Chew, PhD, Christopher L Nobles, PhD, Frederic D. Bushman, PhD, Howard Y. Chang, MD PhD, Ansuman T. Satpathy, MD PhD, Yangbing Zhao, PhD MD, Wei-Ting Hwang, PhD, Elizabeth O. Hexner, MDMS, Carl H June, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 49.
https://doi.org/10.1182/blood-2019-122374
Published: 2019
Journal Articles

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CTL019) in Conjunction with Salvage Autologous Stem Cell Transplantation for Advanced Multiple Myeloma

Alfred L. Garfall, MD, Edward A Stadtmauer, MD, Marcela V. Maus, MD PhD, Wei-Ting Hwang, PhD, Dan T. Vogl, MD, Adam D. Cohen, MD, Brendan M Weiss, MD, David L Porter, MD, Noelle Frey, MD MS, Michael Milone, MD PhD, Patricia Mangan, MSN, CRNP, Maria Krevvata, PhD, Emily Ayers, MD, Karen Dengel, BSN, RN, Naseem DS Kerr, MPH, Simon F. Lacey, PhD, Jan Joseph Melenhorst, PhD, David E Ambrose, BS, Fang Chen, PhD, Vanessa E Gonzalez, M.B.A, Irina Kulikovskaya, PhD, Minnal Gupta, MSc, Jeffrey Finklestein, MSc, Anne Lamontagne, MSc, Matthew O'Rourke, MSc, Megan Suhoski Davis, PhD, Alexander Malykhin, MSc, Bruce L Levine, PhD, Carl H June, MD
Journal: Blood
Blood (2016) 128 (22): 974.
https://doi.org/10.1182/blood.V128.22.974.974
Published: 2016